Elevance Health stock rises 1.86% but lags behind major competitors
Updated
Updated · MarketWatch · Apr 28
Elevance Health stock rises 1.86% but lags behind major competitors
10 articles · Updated · MarketWatch · Apr 28
Elevance Health shares closed at $362.74 on Tuesday, marking their second consecutive day of gains despite a broader market downturn.
The stock remains 14.5% below its 52-week high and saw lower-than-average trading volume at 1.8 million shares.
While Elevance Health underperformed, UnitedHealth, Cigna, and Humana posted stronger gains, highlighting mixed results among major health insurers during a challenging market session.
Why did investors favor rivals over Elevance Health despite its strong earnings report?
Can Elevance Health's Carelon division offset growing pressures in its insurance segments?
Beyond cost-cutting, is AI actually improving patient outcomes at major health insurers?
Are alleged kickbacks by top insurers driving up costs for Medicare Advantage members?
How will flat Medicare Advantage rates affect the benefits for 33 million seniors?
Will the new Medicaid law trigger a healthcare coverage crisis for millions?